Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
14%
Ph early_phase_1
2
29%
Ph not_applicable
2
29%
Ph phase_1
1
14%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 1Safety & dosage
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (33.3%)
Phase 11 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

unknown229%
completed343%
withdrawn114%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7